| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | Prospera SCS System Next Generation Active Anchor, TrueLock |
| Generic Name | Stimulator, spinal-cord, totally implanted for pain relief |
| Applicant | Biotronik Nro, Inc. 6024 Jean Rd. Lake Oswego, OR 97035 |
| PMA Number | P210037 |
| Supplement Number | S002 |
| Date Received | 07/25/2023 |
| Decision Date | 02/15/2024 |
| Product Code |
LGW |
| Advisory Committee |
Neurology |
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the Prospera Spinal Cord Stimulation (SCS) System Next Generation Active Anchor, TrueLock. The Indications for Use (IFU) of the device is as follows:The Prospera spinal cord stimulation (SCS) system is indicated as an aid in the management of chronic, intractable pain in the trunk and/or limbs, which may include unilateral or bilateral pain, resulting from any of the following: 1) Failed Back Syndrome (FBS) or low back syndrome or failed back; 2) Radicular pain syndrome or radiculopathies resulting in pain secondary to FBS or; 3) herniated disk; 4) Post laminectomy pain; 5) Multiple back operations; 6) Unsuccessful disk surgery; 7) Degenerative Disk Disease (DDD)/herniated disk pain refractory to conservative and; 8) surgical interventions; 9) Peripheral causalgia;10) Epidural fibrosis;11) Arachnoiditis or lumbar adhesive arachnoiditis; and12) Complex Regional Pain Syndrome (CRPS), Reflex Sympathetic Dystrophy (RSD), or causalgia. |
|
|